MICROB-PREDICT
@microb-predict.bsky.social
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 825694.
Website: https://microb-predict.eu/
Website: https://microb-predict.eu/
Pinned
On Wednesday, 26 Nov, at 6 pm CET, EASL Studio hosts a new episode titled “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance”
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
On Wednesday, 26 Nov, at 6 pm CET, EASL Studio hosts a new episode titled “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance”
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
November 24, 2025 at 12:05 PM
On Wednesday, 26 Nov, at 6 pm CET, EASL Studio hosts a new episode titled “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance”
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
🎉 Our new #mirobiome paper in #JHEP is out! We found distinct gut #virome shifts in #ACLF - from virulent to temperate #phages - with Lactococcus A + Enterococcus B phages linked to infections & higher 90-day mortality
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
October 24, 2025 at 11:33 AM
🎉 Our new #mirobiome paper in #JHEP is out! We found distinct gut #virome shifts in #ACLF - from virulent to temperate #phages - with Lactococcus A + Enterococcus B phages linked to infections & higher 90-day mortality
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
🌍 The MICROB-PREDICT team met in Münster, Germany from 1–2 October for its 14th Steering Committee Meeting!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
October 24, 2025 at 11:18 AM
🌍 The MICROB-PREDICT team met in Münster, Germany from 1–2 October for its 14th Steering Committee Meeting!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
🚨 New #LiverFailure insights 🚨
In patients with #cirrhosis + acute #decompensation, secretory #IgA strongly correlates with #gut-barrier failure and is a powerful predictor of 90-day mortality in acute-on-chronic #LiverFailure #ACLF
👉 Watch on YouTube: youtu.be/KapUqG7AFFk
#Biomarkers #GutBarrier
In patients with #cirrhosis + acute #decompensation, secretory #IgA strongly correlates with #gut-barrier failure and is a powerful predictor of 90-day mortality in acute-on-chronic #LiverFailure #ACLF
👉 Watch on YouTube: youtu.be/KapUqG7AFFk
#Biomarkers #GutBarrier
September 23, 2025 at 12:40 PM
🚨 New #LiverFailure insights 🚨
In patients with #cirrhosis + acute #decompensation, secretory #IgA strongly correlates with #gut-barrier failure and is a powerful predictor of 90-day mortality in acute-on-chronic #LiverFailure #ACLF
👉 Watch on YouTube: youtu.be/KapUqG7AFFk
#Biomarkers #GutBarrier
In patients with #cirrhosis + acute #decompensation, secretory #IgA strongly correlates with #gut-barrier failure and is a powerful predictor of 90-day mortality in acute-on-chronic #LiverFailure #ACLF
👉 Watch on YouTube: youtu.be/KapUqG7AFFk
#Biomarkers #GutBarrier
👏 ALB-TRIAL hits 50% enrollment 🎉
Half of the planned 240 patients have now been recruited across 14 centres in 7 countries - great progress for the MICROB-PREDICT project!
Huge thanks to all site teams - Onward to full enrollment & better treatment for #cirrhosis patients with #ascites!
#albumin
Half of the planned 240 patients have now been recruited across 14 centres in 7 countries - great progress for the MICROB-PREDICT project!
Huge thanks to all site teams - Onward to full enrollment & better treatment for #cirrhosis patients with #ascites!
#albumin
August 27, 2025 at 12:41 PM
👏 ALB-TRIAL hits 50% enrollment 🎉
Half of the planned 240 patients have now been recruited across 14 centres in 7 countries - great progress for the MICROB-PREDICT project!
Huge thanks to all site teams - Onward to full enrollment & better treatment for #cirrhosis patients with #ascites!
#albumin
Half of the planned 240 patients have now been recruited across 14 centres in 7 countries - great progress for the MICROB-PREDICT project!
Huge thanks to all site teams - Onward to full enrollment & better treatment for #cirrhosis patients with #ascites!
#albumin
Reposted by MICROB-PREDICT
Join this exciting event!
Don't miss our #OpenInnovation event, uniting experts in #DrugDevelopment, #bioinformatics, and #hepatology. Connect with researchers, industry professionals, and investors to share insights & explore collaboration opportunities!
🚀 Register now: inevent.uk/en/Crowdheli...
Don't miss our #OpenInnovation event, uniting experts in #DrugDevelopment, #bioinformatics, and #hepatology. Connect with researchers, industry professionals, and investors to share insights & explore collaboration opportunities!
🚀 Register now: inevent.uk/en/Crowdheli...
May 28, 2025 at 8:21 PM
Join this exciting event!
Don't miss our #OpenInnovation event, uniting experts in #DrugDevelopment, #bioinformatics, and #hepatology. Connect with researchers, industry professionals, and investors to share insights & explore collaboration opportunities!
🚀 Register now: inevent.uk/en/Crowdheli...
Don't miss our #OpenInnovation event, uniting experts in #DrugDevelopment, #bioinformatics, and #hepatology. Connect with researchers, industry professionals, and investors to share insights & explore collaboration opportunities!
🚀 Register now: inevent.uk/en/Crowdheli...
Reposted by MICROB-PREDICT
🧪 SAT-209 – #EASL2025
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
May 10, 2025 at 12:22 PM
🧪 SAT-209 – #EASL2025
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
Reposted by MICROB-PREDICT
🧠 SAT-210 – #EASL2025
New tool alert!
The #mHEST scale brings clarity to grading hepatic #encephalopathy in trials & clinics. A big step for #cirrhosis care. Kudos to Prof. @rajivjalan.bsky.social & his team!
#LiverHealth #HE #ClinicalResearch
New tool alert!
The #mHEST scale brings clarity to grading hepatic #encephalopathy in trials & clinics. A big step for #cirrhosis care. Kudos to Prof. @rajivjalan.bsky.social & his team!
#LiverHealth #HE #ClinicalResearch
May 10, 2025 at 12:23 PM
🧠 SAT-210 – #EASL2025
New tool alert!
The #mHEST scale brings clarity to grading hepatic #encephalopathy in trials & clinics. A big step for #cirrhosis care. Kudos to Prof. @rajivjalan.bsky.social & his team!
#LiverHealth #HE #ClinicalResearch
New tool alert!
The #mHEST scale brings clarity to grading hepatic #encephalopathy in trials & clinics. A big step for #cirrhosis care. Kudos to Prof. @rajivjalan.bsky.social & his team!
#LiverHealth #HE #ClinicalResearch
🔬 Improving the prognostic performance of the #MELD score is a challenge that Nikolaj Torp (Odense University Hospital) took on, comparing the original score with MELD 3.0 in 777 patients with an acute #decompensation of #cirrhosis
#POSTER SAT-196-YI 👏
📅 Presented at #EASLCongress | #EASL2025
#POSTER SAT-196-YI 👏
📅 Presented at #EASLCongress | #EASL2025
May 10, 2025 at 2:00 PM
🔬 Improving the prognostic performance of the #MELD score is a challenge that Nikolaj Torp (Odense University Hospital) took on, comparing the original score with MELD 3.0 in 777 patients with an acute #decompensation of #cirrhosis
#POSTER SAT-196-YI 👏
📅 Presented at #EASLCongress | #EASL2025
#POSTER SAT-196-YI 👏
📅 Presented at #EASLCongress | #EASL2025
Reposted by MICROB-PREDICT
✨ #PosterTour today at #EASLCongress 2025:
All our 3 Horizon2020 #LiverResearch projects in 1 session!
Topic: #Cirrhosis & #PortalHypertension
Chair: Maria Papp
💡 Big moments:
#AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan)
#Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)
All our 3 Horizon2020 #LiverResearch projects in 1 session!
Topic: #Cirrhosis & #PortalHypertension
Chair: Maria Papp
💡 Big moments:
#AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan)
#Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)
May 10, 2025 at 12:04 PM
✨ #PosterTour today at #EASLCongress 2025:
All our 3 Horizon2020 #LiverResearch projects in 1 session!
Topic: #Cirrhosis & #PortalHypertension
Chair: Maria Papp
💡 Big moments:
#AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan)
#Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)
All our 3 Horizon2020 #LiverResearch projects in 1 session!
Topic: #Cirrhosis & #PortalHypertension
Chair: Maria Papp
💡 Big moments:
#AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan)
#Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)
One last time #LIVE from the #EASLStudio: Tot Ziens Amsterdam, Hola Barcelona! 👋
As #EASL2025 draws to a close, Debbie Shawcross and Aleksander Krag reflect on the highlights from Amsterdam and set the stage for #EASL2026 in Barcelona.
Thank you for an inspiring #EASLCongress - see you next year!
As #EASL2025 draws to a close, Debbie Shawcross and Aleksander Krag reflect on the highlights from Amsterdam and set the stage for #EASL2026 in Barcelona.
Thank you for an inspiring #EASLCongress - see you next year!
May 10, 2025 at 10:01 AM
One last time #LIVE from the #EASLStudio: Tot Ziens Amsterdam, Hola Barcelona! 👋
As #EASL2025 draws to a close, Debbie Shawcross and Aleksander Krag reflect on the highlights from Amsterdam and set the stage for #EASL2026 in Barcelona.
Thank you for an inspiring #EASLCongress - see you next year!
As #EASL2025 draws to a close, Debbie Shawcross and Aleksander Krag reflect on the highlights from Amsterdam and set the stage for #EASL2026 in Barcelona.
Thank you for an inspiring #EASLCongress - see you next year!
🧪 Mads Israelsen (Odense Universitetshospital – Svendborg Sygehus) leads together with Alberto Zanetto the YI #Workshop on How to prepare a #Clinical #Practice #Guideline in Hepatology, offering valuable insights for young investigators.
📅 Presented at the #EASLCongress | #EASL2025
📅 Presented at the #EASLCongress | #EASL2025
May 10, 2025 at 9:17 AM
🧪 Mads Israelsen (Odense Universitetshospital – Svendborg Sygehus) leads together with Alberto Zanetto the YI #Workshop on How to prepare a #Clinical #Practice #Guideline in Hepatology, offering valuable insights for young investigators.
📅 Presented at the #EASLCongress | #EASL2025
📅 Presented at the #EASLCongress | #EASL2025
One last time at #EASL2025: Wim Laleman (KUL) hosts the EASL/CIRSE Skills Learning Centre session on #Liver #Haemodynamics, providing hands-on learning in liver disease management.
🕙 10:15 – 11:15, Skills Learning Centre 2
@easlnews.bsky.social @cirsesociety.bsky.social
🕙 10:15 – 11:15, Skills Learning Centre 2
@easlnews.bsky.social @cirsesociety.bsky.social
🔬 EASL/CIRSE Skills Learning Centre: Liver Haemodynamics
Join Wim Laleman (KUL) for an in-depth session on Liver Haemodynamics
📅 Presented at the #EASLCongress | #EASL2025
🕙 10:00 – 11:00
Also available at 12:30, 14:00, and 16:15!
@easlnews.bsky.social @cirsesociety.bsky.social
Join Wim Laleman (KUL) for an in-depth session on Liver Haemodynamics
📅 Presented at the #EASLCongress | #EASL2025
🕙 10:00 – 11:00
Also available at 12:30, 14:00, and 16:15!
@easlnews.bsky.social @cirsesociety.bsky.social
May 10, 2025 at 7:48 AM
One last time at #EASL2025: Wim Laleman (KUL) hosts the EASL/CIRSE Skills Learning Centre session on #Liver #Haemodynamics, providing hands-on learning in liver disease management.
🕙 10:15 – 11:15, Skills Learning Centre 2
@easlnews.bsky.social @cirsesociety.bsky.social
🕙 10:15 – 11:15, Skills Learning Centre 2
@easlnews.bsky.social @cirsesociety.bsky.social
Live from the #EASLCongress: Debbie Shawcross (KCL) presents on Rebooting immunity: Harnessing FMT to revive innate defences in #cirrhosis as part of the Symposium “Microbiome and liver health: Unveiling new therapeutic pathways” 🦠🧫
#EASL2025 @easlnews.bsky.social
@kingscollegelondon.bsky.social
#EASL2025 @easlnews.bsky.social
@kingscollegelondon.bsky.social
May 10, 2025 at 7:29 AM
Live from the #EASLCongress: Debbie Shawcross (KCL) presents on Rebooting immunity: Harnessing FMT to revive innate defences in #cirrhosis as part of the Symposium “Microbiome and liver health: Unveiling new therapeutic pathways” 🦠🧫
#EASL2025 @easlnews.bsky.social
@kingscollegelondon.bsky.social
#EASL2025 @easlnews.bsky.social
@kingscollegelondon.bsky.social
Join us at the Industry Room: Evolving concepts in MASLD, ALD & MetALD at #EASLCongress
Learn about:
✏️ New terminology & pathophysiology
🔬Non-invasive tools for diagnosis, prognosis & monitoring
🚨 Stay updated on the latest in metabolic & alcohol-related liver disease!
#MASLD #MetALD
Learn about:
✏️ New terminology & pathophysiology
🔬Non-invasive tools for diagnosis, prognosis & monitoring
🚨 Stay updated on the latest in metabolic & alcohol-related liver disease!
#MASLD #MetALD
May 10, 2025 at 7:27 AM
Join us at the Industry Room: Evolving concepts in MASLD, ALD & MetALD at #EASLCongress
Learn about:
✏️ New terminology & pathophysiology
🔬Non-invasive tools for diagnosis, prognosis & monitoring
🚨 Stay updated on the latest in metabolic & alcohol-related liver disease!
#MASLD #MetALD
Learn about:
✏️ New terminology & pathophysiology
🔬Non-invasive tools for diagnosis, prognosis & monitoring
🚨 Stay updated on the latest in metabolic & alcohol-related liver disease!
#MASLD #MetALD
👏 What an accomplishment 🥳
Frederike Krus selected for this afternoon's #PosterTour at #EASLCongress
👉 POSTER ID FRI-175
Loss of hepatic #leptin clearance is associated with the development of #ACLF, acute-on-chronic #LiverFailure
📍 #Cirrhosis & Complications
📅 Fri, 9 May
@medblab.bsky.social
Frederike Krus selected for this afternoon's #PosterTour at #EASLCongress
👉 POSTER ID FRI-175
Loss of hepatic #leptin clearance is associated with the development of #ACLF, acute-on-chronic #LiverFailure
📍 #Cirrhosis & Complications
📅 Fri, 9 May
@medblab.bsky.social
May 9, 2025 at 8:50 PM
👏 What an accomplishment 🥳
Frederike Krus selected for this afternoon's #PosterTour at #EASLCongress
👉 POSTER ID FRI-175
Loss of hepatic #leptin clearance is associated with the development of #ACLF, acute-on-chronic #LiverFailure
📍 #Cirrhosis & Complications
📅 Fri, 9 May
@medblab.bsky.social
Frederike Krus selected for this afternoon's #PosterTour at #EASLCongress
👉 POSTER ID FRI-175
Loss of hepatic #leptin clearance is associated with the development of #ACLF, acute-on-chronic #LiverFailure
📍 #Cirrhosis & Complications
📅 Fri, 9 May
@medblab.bsky.social
Reposted by MICROB-PREDICT
Prof. JonelTrebicka presents and discusses the development and success of #TIPS over the past 25 years, high above the rooftops of #Amsterdam.
May 9, 2025 at 7:11 PM
Prof. JonelTrebicka presents and discusses the development and success of #TIPS over the past 25 years, high above the rooftops of #Amsterdam.
Reposted by MICROB-PREDICT
We are ready for #EASLCongress. We are happy to welcome you at our Posters.
May 7, 2025 at 11:50 AM
We are ready for #EASLCongress. We are happy to welcome you at our Posters.
Breaking Barriers 🩺: Novel insights in today's evening Abstract Session on #Alcohol 🍷 at #EASLCongress (Alcohol-related #LiverDisease), co-chaired by Elisa Pose from MICROB-PREDICT partner Fundació Clínic per a la Recerca Biomèdica, FCRB, in Barcelona.
@easlnews.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
May 9, 2025 at 6:02 PM
Breaking Barriers 🩺: Novel insights in today's evening Abstract Session on #Alcohol 🍷 at #EASLCongress (Alcohol-related #LiverDisease), co-chaired by Elisa Pose from MICROB-PREDICT partner Fundació Clínic per a la Recerca Biomèdica, FCRB, in Barcelona.
@easlnews.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
🩺 #POSTER FRI-226 by Wenyi Gu (@medblab.bsky.social at the Universitätsklinikum Münster #UKM) presents her newest results on the burden & impact of #extrahepatic organ failures in European patients with #cirrhosis.
📅 Presented at #EASLCongress | #EASL2025, up until 17h, still time to swing by ☺️
📅 Presented at #EASLCongress | #EASL2025, up until 17h, still time to swing by ☺️
May 9, 2025 at 1:24 PM
🩺 #POSTER FRI-226 by Wenyi Gu (@medblab.bsky.social at the Universitätsklinikum Münster #UKM) presents her newest results on the burden & impact of #extrahepatic organ failures in European patients with #cirrhosis.
📅 Presented at #EASLCongress | #EASL2025, up until 17h, still time to swing by ☺️
📅 Presented at #EASLCongress | #EASL2025, up until 17h, still time to swing by ☺️
🌟 Rising star - first big conference for him, so give him an applause 👏!
Hendrik Rogge presents a great #poster today at #EASLCongress about the 📊 prediction of circulatory failure in intensive-care #patients with liver #cirrhosis & #ACLF.
👉 #POSTER FRI-182, up until 17h
@medblab.bsky.social
Hendrik Rogge presents a great #poster today at #EASLCongress about the 📊 prediction of circulatory failure in intensive-care #patients with liver #cirrhosis & #ACLF.
👉 #POSTER FRI-182, up until 17h
@medblab.bsky.social
May 9, 2025 at 1:02 PM
🌟 Rising star - first big conference for him, so give him an applause 👏!
Hendrik Rogge presents a great #poster today at #EASLCongress about the 📊 prediction of circulatory failure in intensive-care #patients with liver #cirrhosis & #ACLF.
👉 #POSTER FRI-182, up until 17h
@medblab.bsky.social
Hendrik Rogge presents a great #poster today at #EASLCongress about the 📊 prediction of circulatory failure in intensive-care #patients with liver #cirrhosis & #ACLF.
👉 #POSTER FRI-182, up until 17h
@medblab.bsky.social
🔬 Maximilian Brol's #POSTER FRI-493
👉 Conversion from standard-release to prolonged-release tacrolimus mitigates #calcineurin-induced #nephrotoxicity in patients after #LiverTransplantation
The poster is still up until 17:00 today ☺️
📅 Presented at #EASLCongress 2025
@medblab.bsky.social
👉 Conversion from standard-release to prolonged-release tacrolimus mitigates #calcineurin-induced #nephrotoxicity in patients after #LiverTransplantation
The poster is still up until 17:00 today ☺️
📅 Presented at #EASLCongress 2025
@medblab.bsky.social
May 9, 2025 at 12:30 PM
🔬 Maximilian Brol's #POSTER FRI-493
👉 Conversion from standard-release to prolonged-release tacrolimus mitigates #calcineurin-induced #nephrotoxicity in patients after #LiverTransplantation
The poster is still up until 17:00 today ☺️
📅 Presented at #EASLCongress 2025
@medblab.bsky.social
👉 Conversion from standard-release to prolonged-release tacrolimus mitigates #calcineurin-induced #nephrotoxicity in patients after #LiverTransplantation
The poster is still up until 17:00 today ☺️
📅 Presented at #EASLCongress 2025
@medblab.bsky.social
🔬👩🔬 Big news: Loss of hepatic #leptin clearance is associated with the development of acute-on-chronic liver failure #ACLF
#POSTER FRI-175 by Frederike Krus (Universität Münster,
@medblab.bsky.social) - don’t miss it, up until 17h today!
📅 Presented at #EASLCongress 2025
#LiverFailure #cirrhosis
#POSTER FRI-175 by Frederike Krus (Universität Münster,
@medblab.bsky.social) - don’t miss it, up until 17h today!
📅 Presented at #EASLCongress 2025
#LiverFailure #cirrhosis
May 9, 2025 at 12:15 PM
🔬👩🔬 Big news: Loss of hepatic #leptin clearance is associated with the development of acute-on-chronic liver failure #ACLF
#POSTER FRI-175 by Frederike Krus (Universität Münster,
@medblab.bsky.social) - don’t miss it, up until 17h today!
📅 Presented at #EASLCongress 2025
#LiverFailure #cirrhosis
#POSTER FRI-175 by Frederike Krus (Universität Münster,
@medblab.bsky.social) - don’t miss it, up until 17h today!
📅 Presented at #EASLCongress 2025
#LiverFailure #cirrhosis
🎥 LIVE from the #EASLStudio at #EASL2025!
@debbieshawcross.bsky.social (KCL) leads today’s deep dive into “Moving towards recompensation: Putting out the fire that fuels decompensation and ACLF” - tackling the key drivers of decompensation and ACLF, from systemic inflammation to portal hypertension.
@debbieshawcross.bsky.social (KCL) leads today’s deep dive into “Moving towards recompensation: Putting out the fire that fuels decompensation and ACLF” - tackling the key drivers of decompensation and ACLF, from systemic inflammation to portal hypertension.
May 9, 2025 at 10:59 AM
🎥 LIVE from the #EASLStudio at #EASL2025!
@debbieshawcross.bsky.social (KCL) leads today’s deep dive into “Moving towards recompensation: Putting out the fire that fuels decompensation and ACLF” - tackling the key drivers of decompensation and ACLF, from systemic inflammation to portal hypertension.
@debbieshawcross.bsky.social (KCL) leads today’s deep dive into “Moving towards recompensation: Putting out the fire that fuels decompensation and ACLF” - tackling the key drivers of decompensation and ACLF, from systemic inflammation to portal hypertension.
Debbie Shawcross chairs Abstract Session 2 #GeneralHepatology about the hottest #hepatology research.
Highlights: #CALIBRE trial, #fibrosis therapies & #PSC diagnostics. Congrats to Ajay Kumar Duseja & Annalisa Berzigotti on their awards! 🌟
The future of #hepatology looks bright 🌍💡
#EASLCongress
Highlights: #CALIBRE trial, #fibrosis therapies & #PSC diagnostics. Congrats to Ajay Kumar Duseja & Annalisa Berzigotti on their awards! 🌟
The future of #hepatology looks bright 🌍💡
#EASLCongress
May 9, 2025 at 9:58 AM
Debbie Shawcross chairs Abstract Session 2 #GeneralHepatology about the hottest #hepatology research.
Highlights: #CALIBRE trial, #fibrosis therapies & #PSC diagnostics. Congrats to Ajay Kumar Duseja & Annalisa Berzigotti on their awards! 🌟
The future of #hepatology looks bright 🌍💡
#EASLCongress
Highlights: #CALIBRE trial, #fibrosis therapies & #PSC diagnostics. Congrats to Ajay Kumar Duseja & Annalisa Berzigotti on their awards! 🌟
The future of #hepatology looks bright 🌍💡
#EASLCongress